| CAS Number | 875320-31-3 |
| Catalog Number | AG00H1M1(AGN-PC-0WOJRQ) |
| Chemical Name | JNJ26854165(Quisinostat) 2HCl |
| IUPAC Name | N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide;dihydrochloride |
| InChI | InChI=1S/C21H26N6O2.2ClH/c1-26-14-17(18-4-2-3-5-19(18)26)11-22-10-15-6-8-27(9-7-15)21-23-12-16(13-24-21)20(28)25-29;;/h2-5,12-15,22,29H,6-11H2,1H3,(H,25,28);2*1H |
| InChI Key | NRUIZESXVMJDKR-UHFFFAOYSA-N |
| MDL Number | MFCD29905457 |
| Molecular Formula | C21H28Cl2N6O2 |
| Molecular Weight | 467.3920 |
| SMILES | O=C(C1=CN=C(N2CCC(CNCC3=CN(C)C4=C3C=CC=C4)CC2)N=C1)NO.[H]Cl.[H]Cl |
| Synonyms | 875320-31-3,
Quisinostat dihydrochloride,
Quisinostat 2HCl,
Quisinostat (JNJ-26481585) 2HCl,
SCHEMBL20723858,
BCP20792,
JNJ-26481585 2HCl,
SB16529,
S1096,
N-hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide dihydrochloride,
NRUIZESXVMJDKR-UHFFFAOYSA-N,
JNJ26481585,
JNJ-26481585,
Quisinostat 2HCl, 98%, a new type HDAC inhibitor - 100MG 100mg,
|
| Complexity | 533 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 3 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 466.165g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 31 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 467.395g/mol |
| Monoisotopic Mass | 466.165g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 95.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
|
Hazard Class
|
|
|
Hazard statements
|
H302-H315-H319-H335
|
|
Packing Group
|
|
|
Precautionary statements
|
P261-P305+P351+P338
|
|
UN Code
|
|
Certificate of Analysis
Lot Number